Whether or not chronic l-DOPA treatment (100 mg/kg, intraperitoneally (i.p.), twice daily for 4 weeks) alters lipid peroxidation in the brain as an indicator of neuronal damage was examined in normal mice and mice in which catecholamine (CA) neurons had been injured previously by the administration of 6-hydroxydopamine (6-OHDA), followed by recovery. In normal mice, chronic l-DOPA treatment reduced the thiobarbituric acid reacting substances (TBARS) level, an indicator of lipid peroxidation, in the cerebral cortex. In contrast, in mice with CA neuronal injury induced by pretreatment with 6-OHDA, the chronic l-DOPA treatment markedly increased the TBARS in the striatum and frontal cortex, despite recovery of the striatal dopamine levels similar to those in the control mice. These findings suggest that the long-term high-dose administration of l-DOPA enhances the progression of neuronal damage in patients with injured CA neurons such as those with Parkinson's disease.
- Lipid peroxidation
- Neuronal damage
- Parkinson's disease
- Thiobarbituric acid reacting substances (TBARS)
ASJC Scopus subject areas